NUTX as reported
Nutex Health Inc. reported $880M of revenue over the trailing twelve months, +41% on the year before. 11 reported series are charted on this page, each one as filed.
$880M
Revenue, trailing twelve months · to Q1 2026 · +41% against the twelve months before
- Net Income
- $96M
Net Income · +31% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $269M
Free Cash Flow · +287% year on year · trailing twelve months to Q1 2026
- Op Margin
- 30%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $880M | +41% | Q1 2026 |
| Net Income | $96M | +31% | Q1 2026 |
| EPS | $12.94 | +2.2% | Q1 2026 |
| Gross Margin | 45% | n/a | Q1 2026 |
| Op Margin | 30% | n/a | Q1 2026 |
| Net Margin | 11% | n/a | Q1 2026 |
| ROE | 28% | n/a | Q1 2026 |
| ROA | 9.2% | n/a | Q1 2026 |
| ROIC | 120% | n/a | Q1 2026 |
| Free Cash Flow | $269M | +287% | Q1 2026 |
| P/E | 15.1 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Nutex Health Inc. (NUTX) - Revenue & ProfitRevenue & ProfitNutex Health Inc. (NUTX)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Care Facilities
Ranks #10 of 28 by Smart Score